`
`Document Description: Tracane Request
`
`_.
`i3 i O/AiA/stzzt (04-14)
`
`CERTEFECATiC‘iN AND REQEEST FQR PREQRETEZEE} EXAMENATiQN
`
`UMBER 3'? $FR1.102(e)(Pagei cit)
`
`known):
`
`Nonprovisionai Appiication Number (if
`
`AP?LECANT HEREBY CERTEFEES THE FQLLDWENG ANS REQUESTS PRiORiTiZEQ EXAMENATiQN FOR
`THE ABQVE—EDENTiFiEQ A53PLECATEQN.
`
`t. The processing fee set forth in 37 CFR 1.170)“) and the prioritized examination tee set forth in
`37 CPR t.t7(c) have been tiied with the request. The puhiication tee requirement is met
`because that fee, set forth in 37 CFR ’i.tS(d), is currehtiy $6. The basic tiiing tee, search tee,
`and examination tee are fiied with the request or have been aiready been paid.
`i understand
`that any required excess ciaims fees or appiication size fee must he paid for the appiication.
`
`2.
`
`i understand that the appiicatioh may not contain, or he amended to contain, more than four
`independent ciaims, more than thirty totai ciairris, or any rnuitipie dependent oiaims, and that
`any request for an extension of time vviii cause an outstanding Track i request to be dismissed.
`
`3. The appiicahie box is checked heiovv:
`
`i.
`
`iii Qri
`
`
`inaiA iication Track Cine —Prioritized Examination under
`
`
`
`
`i.
`
`(a) The appiication is an origihai nonprovisicnai utiiity appiication tiied under 35 USES. ”i‘itta).
`This certification and request is being tiied with the utiiity appiicatieh via EFS—Weh.
`more"-
`
`(h) The appiication is an originai nonprovisiohai piant appiication tiied under 35 USC. t‘i’iia}.
`This certification and request is being fiied with the piant appiication in paper.
`
`ii. An executed inventor’s oath or deciaration under 37 CFR 1.63 or 37 CFR “E64 for each
`
`inventor, or the appiication data sheet meeting the conditions specified in 37 CPR ”i.53(t)(3)(i) is
`fiied with the appiioation.
`
`ii.
`
`
`“fl Reuest for Continued Examination _ Prioritized Examination under t.‘it)2e2
`
`i. A request for continued examination has been fiied with! or prior to, this form.
`ii.
`if the appiication is a utiiity appiication, this certification and request is being tiied via EFS—Wep.
`iii. The appiication is an originai nonprovisionai utiiity appiication tiied under 35 USC. tii(a), or is
`a nationai stage entry under 35 USO. 3771.
`iv. This certification and request is being fiied prior to the maiiing of a first Office action responsive
`to the request for continued examination.
`v. No prior request for continued examination has been granted prioritized examination status
`under 37 CFR 1.102(e)(2).
`
`SignatureiSCQfi Crgmari
`
`Name
`(Print/Typed)
`
`Scat‘t Crgmar
`
`DateZG1 gwfigw‘j 9
`
`Practitioner
`: Registration Number
`
`55Q66
`
`This form must be signed in accordance with 37 CPR 1.33. See 37 CPR 1.4(0’) for signature requirements and certifications.
`iota:
`Submit militia/e forms if more than one sirnature is required. "
`
`'
`
`forms are submitted.
`
`*Tctai of 1
`
`1
`
`APPLE 1002
`
`1
`
`APPLE 1002
`
`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (PL. 93—579) requires that you be given certain information in connection with your
`submission otthe attached form related to a patent application or patent. Accordingly, pursuant to the requirements of
`the Act, please be advised that: (i) the general authority for the collection otthis information is 35 U.S.C. 2(b}(2); (2)
`turnishing ofthe information solicited is voluntary; and (3) the principal purpose for which the information is used by the
`US. Patent and Trademark: ()ifice is to process and/or examine your suiomission related to a patent application or
`patent.
`it you do not furnish the requested information, the us. Patent and Trademark Office may not be ahle to
`process and/or examine your submission, which may result in termination of proceedings or abandonment oithe
`application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this term will he treated confidentially to the extent allowed underthe Freedom of
`information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 5523). Records from this system of records may
`be disclosed to the Department ofdustice to determine whether disclosure otthese records is required by the
`Freedom of information Act.
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence
`to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of
`settlement negotiations.
`A record in this system of records may be disclosed, as a routine use, to a lvlemher of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from
`the Member with respect to the subject matter olthe record.
`A record in this system of records may be disclosed, as a routine use, to a contractor otthe Agency having
`need forthe information in order to perform a contract. Recipients of information shall be required to comply
`with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552atrn‘}.
`A record related to an international Application filed underthe Patent Cooperation Treaty in this system of
`records may he disclosed, as a routine use, to the international Bureau otthe World intellectual Property
`Ctrganizatlon, pursuant to the Patent Cooperation Treaty.
`A record in this system oi‘ records may be disclosed, as a routine use, to another federal agency i‘or purposes
`of National Security review (35 U.S.C. tSt) and tor review pursuant to the Atomic Energy Act (42 USS.
`218m».
`A record from this system of records may he disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee. during an inspection of records conducted by GSA as part ofthat agency’s
`responsibility to recommend improvements in records management practices and programs, under authority of
`44 U.S.C. 29M and 2906. Such disclosure shall be made in accordance with the GSA regulations governing
`inspection of records iorthis purpose, and any other relevant (rte, GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`A record from this system of records may be disclosed, as a routine use, to the public alter either publication oi
`the application pursuant to 35 iii-35:3. 122th) or issuance of a patent pursuant to 35 U313. 151. Further, a
`record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public tithe record
`was tiled in an application which became abandoned or in which the proceedings were terminated and which
`application is referenced by either a published application, an application open to public inspection or an issued
`patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, lithe USPTO becomes aware of a violation or potential violation of law or regulation.
`
`2
`
`
`
`PTO/ [N82 071
`DOC Code: PA.
`:3
`A
`A(
`u
`.
`_-
`.-
`Approved frir'isse through33/31/2021 or: eoaai0035
`Document Description. Power of Attorney
`1.5 DEPARTMENT OF COB/MERE:E
`US Patent and Trademark Office
`Under the Paperwork Reduction Act of 19355, no persons are required to respond to a collection of in iormatien uniess ii dispiays a valid OMB control number.
`
`TRANEMETTAL FQR PQWER OF ATTQRNEY TE.) (ENE @R NEQRE
`
`REEEESTEREQ PRACTETEQNERS
`
`NOTE: This form is to he submitted with the Fewer of Attorney 'oy Appiieent form {PTO/AiAIBZB) to identify the appiioetien to which the
`Power of Attorney is directed, in accordance with 37 CFR 5, uniess the apoiieation number anti filing date are identified in the Power of
`Attorney by Applicant form.
`if neither form PTO/AiAi’SZA net torn: PTO/AiASZB identifies the aspiieatien te which the Power ofAttcniey is
`ciireetect, the Power ofAttorney t» "' not he recogn:“zedin tf1e application
`
`First Named inventor
`
`Jereen Poeze
`
`WEULTEESTREANE DATA COLLECTEON SYSTEM FOR NGNENVASEVE
`MEASUREMENT GF BLOOD CONSTETUENTS
`
`
`
`SEGNATU RE of A;a.oticent er Patent Prectitiener
`
`[Seett Cremeri
`
`,
`‘ 55066.
`
`Registration
`i Number
`
`i
`“\EGTE: This form must be signed in accordance with 37 (EFF-21.33. See 37 CFR 1.4(d) for signature requirements and certifications. if
`
`eel.
`
`T'h.-s collection of information is required by 3?-"F' 1,131, 1152,3110 1.33. The informa on is required to obtain or retain a benefit by
`
`the public which is to fiie (and bythe USPTO to process) an appiicetion. Confidentiaiit
`.3 governed by 35 USE. 122 and 37 CFR
`i. 11 and 1.14. This eoiiection i3 estimated tc- ta ire 3 minutes to complete, inciuciing gathering, preparing, and submitting the completed
`application form to the LES FTC)"r'ime will vary depending upon the :ndividuai case, Any comments on the amount of time you require
`to comeiete this form andrcrnuggestions for reducing this burden, should be sent to the Chief information Officer, US. Patent and
`Trademark Office, US. Department of Cemmerce, PO. Bex’1450, Aiexandria, VA 22313—41459. DO NQT SEND FEES OR.
`COMPLETED FORMS TC: THES ADDRESS. SEND TC}: Commiesioner for Patents, RC}. Sex “E459, Aiexanctria, VA 22313—1 45%,
`
`i’fyotr need assistance in oompiefing the forme.u‘l 1-800—PTO2799 ands
`
`I'opz‘ion 2
`
`3
`
`
`
`Doc CDds; PA“
`
`u
`P : GiAiAlSEBt07—12)
`.
`A
`.
`Away“ for ”SE through 11/30/2014 OMB 955145035,
`Dawummt Besmipiion: Prrwer oi Attorney
`US Patent anti Trademark Office; US. DEPARTMENT OF COMMERCE
`
`
`
`.ai" n un' s
`' displays a valid OMB c
`iroi number.
`Lindei the Paperwork Reduction Ac! 0! 1.995. rto persons are required to respond In a cottectton at in
`
`
`‘.sxx\xxx\x\xI.\I.\\\xwxxxx5\xx5Iv»x5xx5-\xx5vsx5xx5\xx5vsx5xx5m5Iv»x5xx5\x~5vs-xx5\xx5v;x5xx5\-5v»--5\-5vss~ss5\‘\5vs-~\5\-5v»-~s5\‘s5w\\\»~\ss\v~\~s\\\‘-v-“;‘
`“\“\\“
`“5‘“.th -;-;.;<-.\\“\\\x;..w;“m
`«\w‘N-m‘
`
`PGWER {3F ATTQRNEY BY APFUI‘SANT
`
`«\V‘V;
`
`\\\X\\\\\\\\\\\\\\\\\.\\v«\\\\\\\\\\V\\\\\\\\\\mm\\“\\\\\x\\\\\\\\\xm\\\\\\V\\\\\\\\\\V\\\\vs\\\\x\\\\\xxx\\“\\\\\\\\\x\\\\\\\\\\x\\\\\\\\\\~c\\\\\\\\\\x\\\\w\m\\\\x
`
`
`
`i hereby revekeaiii previwIs powers of att-r trey givgn in the: aripiicatimt identified in the attached transmittal iatter.
`
`i'
`
`with the ioitowing Customer Number as; my/our attorney‘s) ‘ r
`{a ' hereby appoint Pristitionertsi assccia
`Jtranse ctait busim mthe United Statea Pateruit dTrademaik Office connected therewith for the apptication referenced
`in the attached tran2mrtiat letter (formi"iO/AtA/EkA or equivaient):
`
`
`
`
`
`
`
`,
`
`. tt t
`
`
`
`
`tt'i hereby appoint Practitioneris} named beiov. as mymur attorneyts‘ or agenttsi, and to transact ait bus ness in the
`"""‘
`'Jnited Statezs Pat;ant; and Tr.attema'I'k Office coanIzected t'heie-wiih for the apptcation referencedin the ateacheed
`s\\\\\\\\\\\\\\\“\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\A\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\“\\\\x\\\\“\\\\x\\\\“ \\\\\\ \\\\\\x\\\\\\\\\\\\\\\\\\\\\\\\\\“\\\\x\\\\“\\\\\\\\\“\\\\\\\\\\\\\\\\\\\\“\\\\x\\\\“\\\\x\\\\\\\\\\\\ .
`transmittat letter (farm PTO/ALIX/8?A or equivatent):
`Registration
`,
`Registration
`,
`Name
`
`
`
`Number Numbet \\\\\\\\\\).\\\\\\A\\\x\\\\\\x\\m\\\\\\\\\\x\\\\\\\\\\\\\\\\\\\\\x\\\\\\\\\\x\\\\\\\\\\x \\\\A\\\x\\\\\\h\\\x\\\\\
`\\\\\\x\\\\\\\\\\x\\\\\\xg\(p;e\\Kv;vi(“x\\\\\\\c«A\\\\\'\A\\\x\\\\\\h\\\x\\\x\
`I.«fiwmmttmmtmI
`\“\\\\\\\\\w\\\\\\“\\w\
` \\\\\\\m\m\“\\u\\\\\\\\\'~r\\\\\\
`
`\\\\\m\\\\\\\\\\).\\\\\\\\\\).\\\\\~A\\\\\\\\\\\\\\x\\\\\\\\\\x\\\\\\\\\\x\\\\\\ “m“..mm‘m‘m‘“ 5
`
`V\\\\x\\\\v;\\\\x\\\\v;\\\\~.~\\\v;\\\\x\\\\v;\\\\~.~u\\m\\\\~.~u\\»\\smusxsmsssvngxum ->ss\~«\«“«»»nw.
`
`
`wmwwwnmv.“\\\\\“v.“xx“x“vmxx“\\wm\\“\“mw.“““mxxxxnanxx-“x
`
`
`\\\\\\A\\\x\\\\\\h¥x(p;«\V<\(\'\\K«\\\\K\'\VCS\\'\'\'\\x\v\\\\ss\\\\v\\\\~s\~\\m\\\vw~s\m
`
`
` \\ \mumxmmm
`
`\m‘m '
`
`
`
`W“\w‘A\“N\m\\\“mx‘mxm\\“\\m“\\\wmmmmmmwwmmmmmm\wm\xsm
`Wmvm“
`Pieage r—a Cogniza in Change the cor:espondenc-—- addreas for the appi'ication identified-:n the attached
`.
`trarismittat Setter to:
`
`The address associated with the above-mentioned Cu tamer N ‘ her.
`
`0R
`
`S
`M, DR
`i
`i
`I'm: address asmciated .vith’Justomer Number: :
`t
`
`i
`i
`t
`
`t
`t
`
`t tt5
`
`\\u\\\\\\\\w\\\\\\\<¢s\\\\\
`
`t“WWxxIIIw“wwwm‘.Amm\‘Vtmt“\m““mmmmm‘m tv.ttttttt“mt“mmmmm“
`Telephone
`I
`l
`t am the Ampticant:
`i'T!
`Qimvest‘or or .Jcirit inventor
`
`citated inverator
`
`
`ifijAssignc-ze or Person to Wth the inventoris; Under an Qbiigation to As3iqn
`mPerSon Who Sitterwiae Shows; Sufficiwent Proprietary interest(9 g a petition under 37 CFR i.4-6(b)(2) was
`gamma-dtn-the zippiicati-on or is concurrentIy betIng fited with time: document)
`x\v‘\'\:\\\\\\\$\\\\\x\\m\mm\m\x\\\‘\‘i\x{‘\\x\‘\\
`\“\\\\\V\\\\\\\\\\\\\\“\\\\\\NV“w\“\\m\\\\vfisxv.sxxv.\\\\vn\\\\\\\\vs\\\\\\\\\vn\\\\\\\\v-\\'-\x'u'-\\m\\\\\\\\\h\\\\\\\\\“m .
`
`Si-SNARJ 'ItEi at Appiicant tor Patent
`
`3?
`
`ei. Masimot
`
`
`
`rt acmrdanmvit 37 CR? 1.3. See 37 CFR 1,4 for signature requirements: and
`V:Signaiure - ihiES form must be stg .d by the apt ca
`DJ tficatirins. Submit muitipie forms‘:0! mare than One signature, see below ..
`W\'\'\\‘Wm“\\\\w\m\mmm\\“\\\\\\\\m\\\\\\\\\\\\\“\\w\\\\\\\\\\M\\\\\\\\\~A\\\\~.\\\\~A\\\\\~\\«\\\\\\\“\\\\\\\\\y§\\\>\3§\\\\\“y\\\\\\\\\\\\\\\\\\\\Vz\\\\\\\\\\m\\\\\\\\m\\n\\\mwm\fi
`..
`1
`I,
`.
`
`
`ii “formfiare submitted. "Intaiaf -
`WV V V V \\\\\\\\x\\\\\\\\\\\
`
`
`
`
`enetit byihe pub. 3w ,
`.. atotiie (and bythe
`
`
`ion is estimated to take 3 minute-.3 ta wmpiate,
`
`
`
`- caiions’:I;Ir reducing this Plume-113mm id be sén? to the Ch:eii'tinrrrratzon (Niger, U S Fate-
`rriount . .
`.
`i
`i requ .5 to compiete this form arid/a.
`and
`
`Trademark Office, I)S. [Dagxartrneni
`In: CDmmarse,Pi—O. BI, MSG Aiexandt'[BL VA 22313-1450. DO NOT SEND FEES {‘52 CIL?-’\/i¢‘i.ETt:D FORMS TO THES
`ADDRESS SEND T0: Cammifiiorter tor Patenta, 9.0. Sex 1454), Alexandria, VA 22313-1459;
`
`.I'f yau need assistance in campieting the form. cal! 1-I800-PTG-9199 a..d .5lac? opt/o
`
`4
`
`
`
`Docket N0.: MASCER.002C13
`App. N0.:
`Unknown
`Please Direct All Correspondence to Customer Number 64735
`
`Page 1 of 1
`
`RESCISSION OF ANY PRIOR DISCLAIMERS AND REQUEST TO REVISIT ART
`
`Inventor
`
`:
`
`Jeroen Poeze
`
`App. No
`
`: Unknown
`
`Filed
`
`For
`
`: Herewith
`
`: MULTI—STREAM DATA COLLECTION SYSTEM
`FOR N ON IN VASlVE MEAS UREMEN T OF BLOOD
`CONSTITUENTS
`
`Examiner
`
`: Unknown
`
`Art Unit
`
`: Unknown
`
`Conf #
`
`: Unknown
`
`Commissioner for Patents
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`Dear Commissioner:
`
`
`
`The claims of the present application are different and possibly broader in scope than the
`
`claims pursued in the parent application(s).
`
`To the extent any prior amendments or
`
`characterizations of the scope of any claim or referenced art could be construed as a disclaimer of
`
`any subject matter supported by the present disclosure, Applicant hereby rescinds and retracts
`
`such disclaimer. Accordingly, the references previously considered in the parent application(s)
`
`may need to be re-Visited.
`
`Knobbe, Martens, Olson & Bear, LLP
`
`Respectfully submitted,
`
`Dated: August 19, 2019
`
`31160660
`
`/Scott Cromar/
`Scott A. Cromar
`
`Registration No. 65,066
`Registered Practitioner
`Customer No. 64735
`
`(949) 760—0404
`
`5
`
`
`
`Electronic Patent Application Fee Transmittal
`
`——
`——
`
`T't'e °f "New”:
`
`MULTI—STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD CONSTITUENTS
`
`Attorney Docket Number:
`
`MASCER.002C13
`
`Filed as Large Entity
`
`Filing Fees for Trackl Prioritized Examination - Nonprovisional Application under 35 USC 111(a)
`
`
`
`
`
`
`
`Sub-Total in
`Description USD($) Quantity
`
`UTILITY APPLICATION FILING
`
`1311
`
`1817
`
`4000
`
`4000
`
`
`
`Basic Filing:
`
`UTILITY SEARCH FEE
`
`UTILITY EXAMINATION FEE
`
`REQUEST FOR PRIORITIZED EXAMINATION
`
`UTILITY APPL SIZE FEE PER 50 SHEETS >100
`
`Miscellaneous-Filing:
`
`6
`
`
`
`Descr' t'on
`
`Fee Code
`
`ant't
`
`Sub-Total in
`
`PROCESSING FEE EXCEPT PROV APPLS
`
`1830
`
`1
`
`140
`
`140
`
`Total in USD (5)
`
`Patent-Appeals—and Interference:
`
`Post-AlIowance-and-Post-lssuance
`
`Extension-of—Time:
`
`Miscellaneous:
`
`7
`
`
`
`Electronic Acknowledgement Receipt
`
`“—
`
`——
`
`T'tle °f '"Venmm
`
`MULTI—STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD CONSTITUENTS
`
`
`
`“—
`
`——
`
`Utility under 35 USC 111(a)
`Application Type:
`
`
`Payment information:
`
`37 CFR 1.17 (Patent application and reexamination processing fees)
`
`Deposit Account
`
`Authorized User
`
`111410
`
`Daniela Lopez
`
`The Director ofthe USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`37 CFR 1.16 (National application filing, search, and examination fees)
`
`8
`
`
`
`
`
`Document
`Number
`
`Document Descri
`
`tion
`
`p
`
`Application Data Sheet
`
`ADS_002C13.pdf
`
`File Size(Bytes)I
`Message Digest
`1258167
`
`Lb3777fd12afd110345537484c755e5f36d -
`9594
`
`Pages
`Multi
`Part I.zip (if appl.)
`
`-.
`
`354145
`
`SPEC_002C13.pdf
`
`1f62bc77113fc142cd6cb89ffl$d49f109nd]!
`
`Multipart Description/PDF files in .zip description
`
`Document Description
`
`Specification
`
`\I.b
`
`\IU'l
`
`\IO\
`
`Information:
`
`
`
`
`
`Warnings:
`Information:
`
`1408205
`
`
`
`Drawings—other than black and white
`line drawings
`
`FIGSLOOZ-Pdf
`
`92b860c474| |ZEZHaUZI79bEbe37t798bb.
`38d!
`
`Warnings:
`Information:
`
`Oath or Declaration filed
`
`DECS_002.pdf
`
`7015133
`
`77L933397b66d4134c1811584511031263113
`IUEZ
`
`The page size in the PDF is too large. The pages should be 8.5 x 11 or A4. lfthis PDF is submitted, the pages will be resized upon entry into the
`Image File Wrapper and may affect subsequent processing
`
`Information:
`
`9
`
`
`
`TrackOne Request
`
`TRACK1_002C13.pdf
`
`128756
`
`lbc6d2ca$13edc039e8735fa4a413d125c05
`Sat-6
`
`Information:
`
`Power of Attorney
`
`POA7002C13.pdf
`
`541918
`
`ec3132b7331182017347180c417b084ad924
`353(
`
`Warnings:
`Information:
`
`IhI381024h39dIfifiirifidfififiiglhh9r17:
`79cdb
`
`
`Miscellaneous Incoming Letter
`
`
`
`
`RESC_002C13.pdf
`
`Warnings:
`Information:
`
`Information:
`
`Fee Worksheet (SBOG)
`
`fee—info.pdf
`
`b7e56378864034699732867982762439d
`33728
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DOIEOI903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/ROI105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`
`
`10
`
`10
`
`
`
`PTOIAIAI14 (02-18)
`Approved for use through 1113012020. OMB 0651-0032
`U.S. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`-
`
`-
`
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTl—STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`
`CONSTITUENTS
`
`Title of Invention
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.78.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2:
`
`
`CI Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`Inventor Information:
`
`
`
`Middle Name
`
`
`Family Name
`
`0 US Residency
`Non US Residency
`Active US Military Service
`Residence Information (Select One)
`StatelProvince I. country of Residence
`_I ' ancho Santa Margarita
`
`
`Mailing Address of Inventor:
`
`I-3 Tierra Seguro
`Address 1
`I
`Address 2
`_I' ancho Santa Margarita
`
`
`
`StatelProvince
`
`@—
`Legal Name
`
`mmm
`mom
`_IIE
`Active US Military Service
`Residence Information (Select One) © US Residency
`Non US Residency
`
`
`
`Mailing Address of Inventor:
`
`I 0292 Orange Avenue
`Address 1
`I
`Address 2
`_I— Statetvrovince
`Postal Code
`Countryi
`
`nventor
`|3
`Legal Name
`
`I I
`
`IIEI_
`Non US Residency Active US Military Service
`
`
`Residence Information (Select One) © US Residency
`
`EFS Web 2.2.13
`
`11
`
`11
`
`
`
`PTOIAIAI14 (02-18)
`Approved for use through 1113012020. OMB 0651-0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`_
`_
`Attorney Docket Number
`MASCER.OOZC13
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTl-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`Title of Invention
`
`
`
`
`
`
`Country i I
`
`
`
`
`
`
`Middle Name
`
`
`Residence Information (Select One) © US Residency
`Non US Residency
`Active US Military Service
`HI—_I—I_
`
`
`Mailing Address of Inventor:
`
`Address 1'3972 Oswego St.
`
`
`Inventor
`
`Legal Name
`
`Middle Name Family Name
`
`
`
`Prefix Given Name
`
`Residence Information (Select One) © US Residency
`
`Non US Residency
`
`
`
`Active US Military Service
`
`
`Mailing Address of Inventor:
`
`I 8849 Teton Cir
`Address 1
`I
`Address 2
`_I ountain Valley
`
`
`
`StateIProvince
`
`_ L
`
`egal Name
`
`
`
`
`Prefix Given Name
`
`Middle Name
`
`
`Family Name
`
`Residence Information (Select One) 0 US Residency
`
`EFS Web 2.2.13
`
`12
`
`= ruinsma
`0 Non US Residency
`
`Active US Military Service
`
`I-E
`
`12
`
`
`
`PTOIAIAI‘I 4 (02-18)
`Approved for use through 1113012020. OMB 0651-0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Attorney Docket Number
`MASCER.OOZC13
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTl-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`Title of Invention
`
`
`
`Mailing Address of Inventor:
`
`Address 1
`
`I eije Blauwsingel45
`
`
`Inventor
`
`
`Legal Name
`
`Prefix Given Name
`
`
`Middle Name
`
`Family Name
`
`IIEI—
`Residence Information (Select One)
`(9 US Residency 0 Non US Residency
`Active US Military Service
`-I_—I—_
`
`
`Mailing Address of Inventor:
`
`I
`Address 2
`_I— statervrov-nce
`
`
`
`@—
`
`Legal Name
`
`Prefix Given Name
`
`Middle Name
`
`
`Family Name
`
`Residence Information (Select One) @ US Residency 0 Non US Residency
`
`Active US Military Service
`
`
`
`Mailing Address of Inventor:
`
`_I
`
`—I
`_I—
`_I—
`
`Inventor
`
`
`
`Legal Name
`
`IIEI_
`
` Residence Information (Select One) @ US Residency 0 Non US Residency
`
`
` Active US Military Service
`EFS Web 2.2.13
`
`13
`
`13
`
`
`
`PTOIAIAI14 (02-18)
`Approved for use through 1113012020. OMB 0651-0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Attorney Docket Number MASCER.OOZC13
`
`Application Data Sheet 37 CFR 1.76
`_
`_
`Application Number
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`Title of Invention
`
`Country of Residence
`StatelProvince
`
`
`Mailing Address of Inventor:
`
`Address 1
`Address 2
`
`4498 Copper Cliff Court
`
`
`
`licA
`—|— state/Province
`
`Postal Code
`Country i
`I US
`All
`Inventors Must Be Listed — Additional
`Inventor Information blocks may be
`
`generated within this form by selecting the Add button.
`
`
`
`
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`
`For further information see 37 CFR 1.33(a).
`
`D An Address is being provided for the correspondence Information of this application.
`
`Customer Number
`
`I-4735
`
`Application Information:
`
`
`
`
`
`
`
`
`
`mwm D
`
`Total Number of Drawing Sheets (if any) _ Suggested Figure for Publication (if any) '-
`Filing By Reference:
`
`Only complete this section when filing an application by reference under 35 U.S.C. 1 I 1 (c) and 37 CFR1.57(a). Do not complete this section if
`application papers including a specification and any drawings are being filed. Any domestic benefit or foreign priority information must be
`provided in the appropriate section(s) below (i.e., "Domestic Benefit/National Stage Information" and "Foreign Priority Information”).
`
`For the purposes of a filing date under 37 CFR1.53(b), the description and any drawings of the present application are replaced by this
`
`reference to the previously filed application, subject to conditions and requirements of 37 CFR 1.57(a).
`.I
`
`Application number of the previously
`filed application
`
`Filing date (YYYY—MM-DD)
`
`Intellectual Property Authority or Country
`
`
`
`fififi
`
`
`Publication Information:
`
`
`
`
`Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`Request Not to Publish. I hereby request that the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`
`publication at eighteen months after filing.
`
`EFS Web 2.2.13
`
`14
`
`14
`
`
`
`PTOIAIAI14 (02-18)
`Approved for use through 1113012020. OMB 0651-0032
`U.S. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Attorney Docket Number
`MASCER.OOZC13
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTl-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`
`CONSTITUENTS
`
`Title of Invention
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`US Patent Practitioner O Limited Recognition (37 CFR 11.9)
`
`0 Customer Number
`
`Please Select One:
`
`Domestic BenefitINational Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) or indicate
`National Stage entry from a PCT application. Providing benefit claim information in the Application Data Sheet constitutes
`the specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`When referring to the current application, please leave the "Application Number” field blank.
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing or 371(c) Date
`(yvyy-M|\/|-DD)
`
`Prior Application Status_I
`Application
`Prior Application
`I16/534949
`I'"16l409515
`
`
`Remove
`
`
`Issue Date
`(FiIYYYiyng Date
`IrO19—05—10I10376191I019—08—13
`
`Application
`
`.
`
`.
`
`Prior Application
`
`Filing Date
`
`ISSUE Date
`
`I16l409515
`
`I ontinuation of
`
`I I16I261326
`
`'019—05—21
`10292628
`'019—01—29
`
`
`
`
`
`
`Issue Date
`Filing Date
`Prior Application
`.
`.
`Application
`
`Number
`Continuity Type
`Number
`(YYYY-MM-DD)
`(YYYY-MM-DD)
`Patent Number
`
` l2018—12—06 10258266 2019-04-16
`16/261326
`ontinuation of
`I 16/212537
`
`
`Prior Application Status_I
`Remove
`Application
`Prior Application
`I16/212537
`I_I14I981290
`
`
`
`Filing Date
`Ir 015—12—28
`
`I10335068
`
`Issue Date
`I019—07—02
`
`EFS Web 2.2.13
`
`15
`
`15
`
`
`
`PTO/AlA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`Attorney Docket Number MASCER.002013
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTl-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`Title of Invention
`
`'
`'
`Application
`Number
`
`Continuity Type
`
`
`
`
`
`
`Remove
`
`
`
`
`
`'
`'
`'
`"
`Issue Date
`
`Patent Number
`Prior Application
`Filing Date
`
`
`Number
`(YYYY—MM—DD)
`(YYYY—MM—DD)
`
`I_-_IIII-I
`
`
`—_II
`
`Filing or 371(c) Date
`
`
`Prior Application Number
`
`
`(YYYY-MM—DD)
`
`Application Number
`
`Continuity Type
`
`I__ll
`
`' 1309—08—03
`
`
`Remove
`
`
`
`Filing or 371(c) Date
`
`
`
`Prior Application Number
`(YYYY-MM-DD)
`
`
`
`
`'008—08—04
`
`
`Filing or 371(c) Date
`(yvyy-M|\/|-DD)
`
`I 61/086060
`
`Prior Application Number
`
`
`
`
`
`I 61/086108
`'008—08—04
`
`
`
`Filing or 371(c) Date
`(YYYY-MM-DD)
`
`
`I 61/086063
`'008-08—04
`
`
`
`
`
`
`
`
`
` Prior Application Number
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Application Number
`
`Continuity Type
`
`I 2/534827
`
`I laims benefit of provisional
`
`Application Number
`
`Continuity Type
`
`'—2/534827
`
`I laimsbenefitofprovisional
`
`Application Number
`
`Continuity Type
`
`I 2/534827
`
`I laims benefit of provisional
`
`Application Number
`
`Continuity Type
`
`Application Number
`
`Continuity Type
`
`I 2/534827
`
`I laims benefit of provisional
`
`Prior Application Number
`
`Filing or 371(c) Date
`(YYYY-MM-DD)
`
`
`
`I008-0804
`I 61/086057
`I laims beneft of prOVISIonal
`I 21534027
`
`
`_emove
`Prior Application Status_I
`Fil-in-gor 371(c) Date
`
`
`
`Prior Application Number
`(YYYY-MM-DD)
`
`
`
`I 61/091732
`'008—08—25
`
`
`
`
`Iv013—11—05
`[577431
`I'009'07'02
`
`
`
`Filing or 371(c) Date
`
`
`
`
` Prior Application Number
`(YYYY-MM-DD)
`
`
`Application
`
`.
`
`.
`
`Prior Application
`
`Filing Date
`
`Issue Date
`
`I12/829352
`
`I ontinuation in part of l I12/497528
`
`Application Number
`
`Continuity Type
`
`I 2/497523
`
`I laims benefit of provisional
`
`I 61/086060
`
`I008—08—04
`
`EFS Web 2.2.13
`
`16
`
`16
`
`
`
`PTO/AlA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Attorney Docket Number MASCER.002013
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTl-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`Title of Invention
`
`Remove
`
`
`
`
`
`Filing or 371(c) Date
`
`
`
` Prior Application Number
`(YYYY-MM-DD)
`
`
`'008—08—04
`
`
`Filing or 371(c) Date
`(yvyy-M|\/|-DD)
`
`Prior Application Number
`
`I 61/086108
`
`Application Number
`
`Continuity Type
`
`I 2/497528
`
`I laims benefit of provisional
`
`Application Number
`
`Continuity Type
`
`Application Number
`
`Continuity Type
`
`
`
`
`
`
`
`
`
`
`
`I 61/086063
`I laims benefit of provisional
`I 21497528
`'008—08—04
`
`
`
`
`Prior Application Status Im:
`Remove
`
`
`
`Filing or 371(c) Date
`
`
`
`
` Prior Application Number
`(YYYY-MM-DD)
`
`I008-0804
`I 61/086057
`I laims beneft of prOVISIonal
`I 2/497528
`
`
`_emove
`Prior Application Status Im:
`Fil-in_gor 371(c) Date
`
`
`
`Prior Application Number
`(YYYY-MM-DD)
`
`
`' 008—07—03
`I 61/078228
`
`
`Remove
`
`
`
`
`Filing or 371(c) Date
`
`
`
`Prior Application Number
`(YYYY-MM-DD)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Application Number
`
`Continuity Type
`
`I 2/497528
`
`I laims benefitof provisional
`
`Application Number
`
`Continuity Type
`
`'—2/497528
`
`I laimsbenefitofprovisional
`
`
`
`
`
`'008—07—03
`I 61/078207
`Filingor 371(c) Date
`
`
`
`
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`(YYYY-MM-DD)
`
`I 21497528
`
`I laims benefit of provisional
`
`I 61/091732
`
`'008—08—25
`
`
`Issue Date
`Filing Date
`Prior Application
`.
`.
`Application
`
`Continuity Type
`(YYYY—MM—DD)
`(YYYY—MM—DD)
`Patent Number
`
`'008-08—25
`D606659
`'009— 12—22
`
`
`
`
`
`Application
`
`.
`
`.
`
`PriorApplication
`
`Filing Date
`
`-|SSUG Date
`
`I12/497528
`
`I ontinuation in part